Check out the companies making headlines in the midday trading: High-tech stocks – Megacup technology name stocks rose amid investor optimism that the US will reach deals with other countries to lower tariffs. Apple, which lost about 20% in the last three days in light of China’s exposure, has risen by more than 3%. Others like Nvidia and Tesla also won, up about 6% and nearly 5% respectively. Major health insurance stocks have flew after the Centers for UnitedHealth Group in Humana – Medicare and Medicaid Services announced a higher than expected increase due to government payments for Medicare Advantage plans. UnitedHealth shares rose 6.7%, while Humana shares rose 10.8%. Wells Fargo – After Piper Sandler upgraded Wells Fargo from neutral to overweight, bank shares have climbed nearly 4%. Piper Sandler said the bank giant’s stock has an attractive rating that properly captured the company’s improved fate. Broadcom – Chip stocks had won more than 7% after the company approved a $10 billion stock repurchase program by the end of 2025. The announcement of the approval “reflects the board’s trust in the strength of Broadcom’s diversified semiconductor and infrastructure software product franchise,” Hock Tan said in a statement. Marvell Technology – The stock has won over 7% after agreeing to sell its automated Ethernet business to Infineon Technologies in all-cash transactions worth $2.5 billion. The transaction is expected to close within 2025. Lockheed Martin – Shares rose 4% amid wider advancements in defense companies after President Donald Trump pledged a full year’s $1 trillion defense budget. Janover – Stocks fell by more than 31%, turning the course from more than 800% meetings in the previous session after the software company announced its cryptocurrency strategy focusing on Solana Token. Janover will also be revising its name and ticker symbol. Charles Schwab – Financial stocks popped 4.5% shortly after Morgan Stanley upgrade. Morgan Stanley said he prioritizes brokers with defensive revenue streams and singular drivers for revenue growth. Eli Lilly – Pharma Stock added 3% after Goldman Sachs took on name compensation in the purchase rating. Analyst Asad Haider said he is seeing “persuasive entry points” for stocks at the current level. Greenbrier – The railroad car manufacturer lost 4% after cutting year-round revenue guidance. Greenbrier currently expects revenues of between $3.15 billion and $33.5 million against guidance of $3.35 billion to $3.35 billion. TILRAY Brand – Stocks plummeted more than 11% after posting a weaker than expected third quarter results. Tilray reported an adjusted EBITDA of $9 million, below the $9.7 million expected by analysts voted by Factset. Due to net revenue, the company recorded $185.8 million. Similarly, consensus estimates are below $210 million. Tilray also narrowed its full-year forecast. – CNBC’s Alex Hurling, Jesse Pound, Sarah Minh, Yun Lee, Lisa Kailay Han and Michelle Fox reported.
